1. Home
  2. ASTH vs IDYA Comparison

ASTH vs IDYA Comparison

Compare ASTH & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$23.68

Market Cap

1.1B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$34.04

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
IDYA
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ASTH
IDYA
Price
$23.68
$34.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
14
Target Price
$41.33
$49.42
AVG Volume (30 Days)
489.7K
913.9K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$2,896,452,000.00
$214,834,000.00
Revenue This Year
$58.37
$2,434.86
Revenue Next Year
$25.48
N/A
P/E Ratio
$122.28
N/A
Revenue Growth
68.17
5377.66
52 Week Low
$20.12
$13.45
52 Week High
$39.97
$37.08

Technical Indicators

Market Signals
Indicator
ASTH
IDYA
Relative Strength Index (RSI) 49.51 54.27
Support Level $20.64 $33.12
Resistance Level $23.23 $37.08
Average True Range (ATR) 0.95 1.45
MACD 0.35 -0.31
Stochastic Oscillator 94.93 24.75

Price Performance

Historical Comparison
ASTH
IDYA

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: